Tilray Brands, Inc. (TLRY)

Tilray Brands’ revenue and EPS both trailed consensus in the first fiscal quarter of 2027 (period ended August 31, 2026) that it reported on October 8, 2026, with revenue down 10.6% year over year to roughly $257.1 million. Revenue of $257.1 million trailed the $266.3 million estimate, -3.4%, while EPS of -$0.32 trailed the -$0.18 estimate by -$0.14, down from $0.20 a year ago. Gross profit came in at about $77.5 million, translating to a gross margin of ~30.1%, and the company posted an operating loss of roughly $16.0 million for an operating margin of about -6.2%. Net income was -$40.0 million versus -$442,312.00 a year ago, and the quarter generated negative operating cash flow of about $16.5 million. Tilray operates across Cannabis, Distribution, Beverage Alcohol, and Wellness, spanning medical and adult-use cannabis products, procured pharmaceutical and wellness goods for resale, alcoholic beverages, and hemp-derived food and related wellness items. Next-period consensus calls for EPS of -$0.19 on revenue of $267.0 million.